Stereotactic hypofractive radiotherapy in the treatment of patients with lung cancer

Stereotactic hypofractive radiotherapy in the treatment of patients with lung cancer

Introduction. Nowadays the stereotactic radiotherapy (SRT) of patients with clinical stage I-II lung cancer is the choice of the treatment modality for functionally inoperable patients. It shows safety and high efficiency in reaching the local control. Though there is a range of unsolved issues conn...

Full description

Bibliographic Details
Main Authors: T. N. Borisova, A. V. Nazarenko, K. K. Laktionov, S. I. Tkachev, S. B. Alieva, V. V. Breder, O. P. Trofimova, V. V. Glebovskaya, A. A. Fedorova, D. T. Marinov, N. A. Meshcheriakova, S. M. Ivanov, S. G. Gerasimov
Format: Article
Language:Russian
Published: Remedium Group LLC 2020-12-01
Series:Медицинский совет
Subjects:
stereotactic radiotherapy
lung cancer
overall survival
disease-specific survival
radiation toxicity
predictor factors
Online Access:https://www.med-sovet.pro/jour/article/view/5949

Internet

https://www.med-sovet.pro/jour/article/view/5949

Similar Items